Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/1999
06/09/1999EP0920864A1 Combination therapy including a specific beta-3 agonist and an anorectic agent
06/09/1999EP0920528A1 Synthetic protein folding catalysis
06/09/1999EP0920518A1 Stimulus-inducible i (kappa)b kinase ikk] signalsome
06/09/1999EP0920507A2 Secreted proteins and polynucleotides encoding them
06/09/1999EP0920506A1 Human dbi/acbp-like protein
06/09/1999EP0920503A2 A novel human leptin receptor gene-related protein
06/09/1999EP0920500A1 Human proteolipid
06/09/1999EP0920494A2 Pro-protein converting enzyme
06/09/1999EP0920438A2 N6 heterocyclic substituted adenosine derivatives
06/09/1999EP0920431A1 Thienopyrimidines
06/09/1999EP0920430A1 Purine derivatives and their use as anti-coagulants
06/09/1999EP0920429A1 Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
06/09/1999EP0920428A1 Non-symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis
06/09/1999EP0920425A1 Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
06/09/1999EP0920422A1 Crytalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide
06/09/1999EP0920315A1 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists
06/09/1999EP0920310A1 Use of aminothiolester derivatives in pharmaceutics
06/09/1999EP0775103B1 Retinoic acid x-receptor ligands
06/09/1999EP0763012B1 Succinyl hydroxamic acid, n-formyl-n-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors
06/09/1999EP0752981B1 Substituted cyclopentylamine derivatives and their use as calcium channel antagonists
06/09/1999EP0751932B1 Vitamin-d amide derivatives
06/09/1999EP0666738B1 Inhibitors of farnesyl-protein transferase
06/09/1999EP0647636B1 Benzothiazole compound, process for producing the same, and use thereof
06/09/1999CN1219174A Inhibitors of protein farnesyl transferase
06/09/1999CN1219173A Pyrroloazepine compounds
06/09/1999CN1219172A Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
06/09/1999CN1219171A Benzofuran carboxamides and their therapeutic use
06/09/1999CN1219170A Substituted 1,2,3,4-tetrahydronaphthalene derivatives
06/09/1999CN1219168A Quinoline carboxamides as TNF inhibitors and as PDC-IV inhibitors
06/09/1999CN1219166A Biphenylsulfonamide matrix metalloproteinase inhibitors
06/09/1999CN1219131A Quinoline carboxamides as TNF inhibitors and as PDC-IV inhibitors
06/09/1999CN1219104A Method of treating renomous bites and stings
06/09/1999CN1218808A Dithio-heterocyclic-pentylene acetamide derivatives
06/09/1999CN1218802A Substituted isoquinoline-3-formamides compounds, its preparing method and its use as medicine
06/09/1999CN1218801A Tri-substituted imidazoles, and process of their preparation and using the same and having their pharmic composition
06/09/1999CN1218671A Nutritive liquid for nourishing brain and promoting intelligence growth
06/09/1999CN1218666A Nef function inhibitor
06/08/1999US5910609 Compounds
06/08/1999US5910586 Tricyclic aminoalkylcarboxamides; dopamine D3 receptor subtype specific ligands
06/08/1999US5910513 Substituted benzyl derivatives of polyalkylene polyamines and their use in cosmetic and pharmaceutical compositions
06/08/1999US5910508 Novel compounds useful in modulating cellular hormone receptors; treating skin disorders such as acne, psoriasis
06/08/1999US5910499 Leukotriene production inhibiting action and antihistaminic action; oral administration
06/08/1999US5910490 Inhibition of membrane receptors for elastin which are involved in degradation of fibrous stroma of the connective tissue
06/08/1999US5910435 Exposing protein with non-native disulfide bonds to non-protein compound with pka less than 8 and eo greater than -0.25 volts; for proper conformation of heterologous eukaryotic proteins from prokaryotic hosts
06/08/1999US5910431 Polynucleotides encoding chemokine α-2
06/08/1999US5910307 Process of extracting and purifying biologically effective ingredients from combined medicinal plants and their extract composition
06/08/1999CA2242308A1 Novel compounds
06/08/1999CA1340588C Amino acid derivatives
06/04/1999CA2255180A1 N-(4-carbamimido-phenyl)-phenylglycinamid derivatives
06/03/1999WO1999027134A1 Antisense oligonucleotide modulation of human serine/threonine protein phosphatase gene expression
06/03/1999WO1999027104A1 Histamine and serotonin binding molecules
06/03/1999WO1999027103A1 Mammalian cytokine-like polypeptide-10
06/03/1999WO1999027094A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
06/03/1999WO1999027080A2 Human protein kinase and kinase inhibitors
06/03/1999WO1999027078A1 Chemokine alpha-5
06/03/1999WO1999027077A1 Method for producing human intervertebral disc cells
06/03/1999WO1999026966A2 Nuclear receptor ligands and ligand binding domains
06/03/1999WO1999026954A1 Mitochondrially targeted antioxidants
06/03/1999WO1999026944A1 New compounds which are p2-purinoceptor 7-transmembrane (tm) g-protein coupled receptor antagonists
06/03/1999WO1999026943A1 Thrombin receptor antagonists
06/03/1999WO1999026942A1 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
06/03/1999WO1999026929A1 Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
06/03/1999WO1999026927A2 Metabotropic glutamate receptor antagonists for treating central nervous system diseases
06/03/1999WO1999026926A1 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
06/03/1999WO1999026924A1 Substituted oximes as neurokinin antagonists
06/03/1999WO1999026921A1 SUBSTITUTED β-ALANINE DERIVATIVES AS CELL ADHESION INHIBITORS
06/03/1999WO1999026909A2 Alpha-hydroxy, -amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors
06/03/1999WO1999026664A1 Recombinant mycoplasma hyopneumoniae vaccine
06/03/1999WO1999026660A2 Conjugates of cytokines and drugs or genes for treating proliferating cells
06/03/1999WO1999026659A1 Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor
06/03/1999WO1999026655A1 Method for inhibiting premature rupture of fetal membranes, ripening of uterine cervix and preterm labor
06/03/1999WO1999026652A1 Mucosal delivery system comprising lipophilic thrombin inhibitors
06/03/1999WO1999026650A1 ribB
06/03/1999WO1999026647A1 Use of heparin-binding protein for the modulation or prophylaxis of apoptosis of mammalian cells
06/03/1999WO1999026646A1 ribA
06/03/1999WO1999026645A1 Method of mobilizing hematopoietic stem cells
06/03/1999WO1999026644A1 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
06/03/1999WO1999026643A1 Methods of preparation of bioginkgo
06/03/1999WO1999026632A1 Phospholipids having antimicrobial activity with or without the presence of antimicrobials
06/03/1999WO1999026630A1 Testosterone inhibitors and use for the protection of neurons
06/03/1999WO1999026629A1 Ep2-receptor agonists as neuroprotective agents for the eye
06/03/1999WO1999026628A1 Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour
06/03/1999WO1999026624A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhe and scours
06/03/1999WO1999026616A1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use
06/03/1999WO1999026615A1 Cyclic amino acid derivatives as cell adhesion inhibitors
06/03/1999WO1999026609A2 Therapeutic treatment for chronic myeloid leukemia and acute lymphoid leukemia
06/03/1999WO1999026604A2 Selected c10 perfluorinated hydrocarbons for liquid ventilation and artificial blood
06/03/1999WO1999026583A2 Inhibtion of lipoprotein oxidation
06/03/1999WO1999026582A2 Mitochondrially targeted compounds
06/03/1999WO1999026476A1 New psoralens for pathogen inactivation
06/03/1999WO1999014242A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/03/1999WO1999013871A3 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents
06/03/1999WO1999012965A3 April- a novel protein with growth effects
06/03/1999WO1999007729A3 Peptides having potassium channel opener activity
06/03/1999WO1999005096A3 Urokinase inhibitors
06/03/1999CA2316340A1 Phospholipids having antimicrobial activity with or without the presence of antimicrobials
06/03/1999CA2314096A1 Nuclear receptor ligands and ligand binding domains
06/03/1999CA2312000A1 Mammalian cytokine-like polypeptide-10
06/03/1999CA2311969A1 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
06/03/1999CA2311809A1 Method for inhibiting premature rupture of fetal membranes, ripening of uterine cervix and preterm labor
1 ... 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 ... 1564